Researchers propose new disease classification system for obesity

February 24, 2020

SILVER SPRING, Md.--Researchers are proposing a new scientifically correct and medically actionable disease classification system for obesity, according to a paper published online in Obesity, the flagship journal of The Obesity Society.

The proposed disease classification system is based on the concept Adiposity-Based Chronic Disease (ABCD). The diagnostic term reflects both the pathophysiology and clinical impact of obesity as a chronic disease. The proposed coding system has four domains: pathophysiology, body mass index (BMI) classification, complications, and complication severity; and incorporates disease staging, specific complications that impact health, the basis for clinical intervention, individualized treatment goals and a personalized medicine approach.

"The coding reflects 'what we are treating' and 'why we are treating it', and, hopefully, will provide impetus for greater access of patients to evidence-based treatments," said W. Timothy Garvey, MD, Butterworth Professor in the Department of Nutrition Sciences and Director of the Diabetes Research Center at the University of Alabama at Birmingham. Garvey is also a GRECC investigator and staff physician at the Birmingham Department of Veterans Affairs Medical Center. Garvey is the corresponding author of the study.

The diagnosis of obesity is currently based only on BMI that conveys no indication of the impact of excess adiposity on a person's health. The International Classification of Diseases (ICD) code for obesity reads "obesity due to excess calories," which experts say is not medically meaningful and does not reflect obesity pathogenesis.

"These inadequacies contribute to lack of access of patients to evidence-based therapies and appreciation of obesity as a chronic disease," said Garvey.

The American Association of Clinical Endocrinologists (AACE) and the European Association for the Study of Obesity (EASO) have both embraced the concept of ABCD.

"There is increasing recognition globally that BMI and other simple metrics of obesity do not accurately reflect the complexity of the disease or the circumstances of patients. The Garvey and Mechanick proposal for a scientifically accurate and medically actionable four domain classification system is most welcome, and builds on previous initiatives of the AACE and EASO, explaining obesity as an 'adiposity-based chronic disease.' It is time for obesity to enter the era of precision medicine, with novel classification systems based on functionally established endpoints," said Gema Frühbeck, first author of the EASO paper on ABCD.

"AACE has historically supported efforts in advancing the clinical evaluation and therapy of obesity beyond just a disease of weight based upon BMI, including guidelines recommending more nuanced diagnosis based upon exam and clinical evaluation to classify and stage the severity of disease. It is critical to match the intensity of therapy to the severity of disease and pathophysiology of disease, thus AACE followed its guidelines with a position statement proposing ABCD as a new diagnostic term for obesity. This proposed ICD coding structure supports the clinical efforts of personalizing individual diagnoses with more precision and nuance, which will benefit customized therapeutic plans for patients with obesity," said Karl Nadolsky, DO, FACE, chair of the Nutrition and Obesity Disease State Network at AACE.

"The framework provides a well-organized way to help practitioners and payers conceptualize obesity beyond an erroneous framework of this patient eats too much and is not active enough," said Jamy Ard, MD, professor of epidemiology and prevention at Wake Forest School of Medicine and co-director of the Weight Management Center at Wake Forest Baptist Health in Winston-Salem, NC. Ard was not associated with the research.

Ard added that the biggest challenge he foresees with this approach is that providers currently underdiagnose obesity using the simple BMI-based coding. "This more advanced approach will require a significant amount of education and outreach to change providers' behaviors. However, if better reimbursement is tied to this type of coding system as the authors aspire, it may help to drive broader adoption and implementation," said Ard.
-end-
Other authors of the study include Jeffrey Mechanick of the Marie-Josée and Henry R. Kravis Center for Clinical Cardiovascular Health at Mount Sinai Heart in New York City and the Icahn School of Medicine at Mount Sinai.

Garvey has served on ad hoc advisory boards for Sanofi, Novo Nordisk, Boehringer-Ingelheim, Gilead, Amgen, BOYDSense and the American Medical Group Association. He has conducted research sponsored by the University of Alabama at Birmingham and funded by Sanofi, Merck/Pfizer, Novo Nordisk and Astra Zeneca. Mechanick has received honoraria for lectures and program development from Abbott Nutrition International.

The paper, titled "Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity" will be published in the March 2020 print issue.

The Obesity Society (TOS) is the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity and its adverse health, economic and societal effects. Combining the perspective of researchers, clinicians, policymakers and patients, TOS promotes innovative research, education, and evidence-based clinical care to improve the health and well-being of all people with obesity. For more information, visit http://www.obesity.org and connect with us on Facebook, Twitter and LinkedIn.

The Obesity Society

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.